ALPN
Alpine Immune Sciences Inc
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
56 hedge funds and large institutions have $222M invested in Alpine Immune Sciences Inc in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% less capital invested
Capital invested by funds: $257M → $222M (-$35.3M)
Holders
56
Holding in Top 10
3
Calls
$27K
Puts
–
Top Buyers
| 1 | +$3.02M | |
| 2 | +$2M | |
| 3 | +$1.24M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$333K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$166K |
Top Sellers
| 1 | -$24.7M | |
| 2 | -$15.5M | |
| 3 | -$3.19M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$1.24M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$1.22M |